STOCK TITAN

Director at Delek US (DK) receives 3,436-share stock grant, now holds 10,082

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zohar Shlomo reported acquisition or exercise transactions in this Form 4 filing.

Delek US Holdings, Inc. director Zohar Shlomo received a grant of 3,436 shares of common stock, recorded at a price of $48.01 per share. This was a compensation-related award, not an open-market purchase. Following the grant, Shlomo directly holds 10,082 common shares.

Positive

  • None.

Negative

  • None.
Insider Zohar Shlomo
Role null
Type Security Shares Price Value
Grant/Award Common Stock 3,436 $48.01 $165K
Holdings After Transaction: Common Stock — 10,082 shares (Direct, null)
Footnotes (1)
Shares granted 3,436 shares Equity grant to director on 2026-06-10
Grant price $48.01 per share Reported transaction price for the award
Shares after transaction 10,082 shares Director’s direct holdings following the grant
Transaction code A (grant, award, or other acquisition) Indicates compensation-related share acquisition
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
direct ownership financial
"ownership_type: "direct""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Delek US Holdings (DK) report for Zohar Shlomo?

Delek US Holdings reported that director Zohar Shlomo received a grant of 3,436 common shares. The award was recorded at $48.01 per share, reflecting a compensation-related acquisition rather than an open-market stock purchase.

How many Delek US Holdings (DK) shares does Zohar Shlomo hold after this Form 4?

After the reported grant, director Zohar Shlomo directly holds 10,082 shares of Delek US common stock. This total includes the newly granted 3,436 shares and represents his direct ownership position following the compensation award.

Was the Delek US (DK) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant or award acquisition coded as “A,” not an open-market stock purchase. Zohar Shlomo received 3,436 common shares as a compensation-related award recorded at $48.01 per share.

What was the reported price for the Delek US (DK) shares granted to Zohar Shlomo?

The 3,436 Delek US common shares granted to director Zohar Shlomo were recorded at $48.01 per share. This figure is the transaction price used in the Form 4, typical for reporting the fair value of equity awards.

Does the Delek US (DK) Form 4 show any insider sales by Zohar Shlomo?

The Form 4 does not report any insider sales by Zohar Shlomo. It records only a single acquisition transaction coded as a grant or award of 3,436 common shares, increasing his direct holdings to 10,082 shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zohar Shlomo

(Last)(First)(Middle)
310 SEVEN SPRINGS WAY
SUITE 500

(Street)
BRENTWOOD TENNESSEE 37027

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026A3,436A$48.0110,082D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Misty Lavender, Attorney in Fact06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)